Xintela AB (OSTO:XINT) Total Operating Expense : kr53.21 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Total Operating Expense?

Xintela AB's Total Operating Expense for the three months ended in Mar. 2024 was kr11.10 Mil. Xintela AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr53.21 Mil.

Xintela AB Total Operating Expense Historical Data

The historical data trend for Xintela AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xintela AB Total Operating Expense Chart

Xintela AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

Get a 7-Day Free Trial

38.08

33.90

60.07

69.06

57.32

Xintela AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Operating Expense	Get a 7-Day Free Trial															15.21	17.55	12.30	12.26	11.10

Xintela AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr53.21 Mil.

Xintela AB Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Xintela AB's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Xintela AB (OSTO:XINT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Medicon Village, Lund, SWE, 22381

Website

http://www.xintela.se

Xintela AB is a biomedical company which utilises its proprietary marker technology XINMARK to develop stem cell-based therapies (XSTEM) for osteoarthritis and antibody-based therapies for Glioblastoma and Tripple-negative breast cancer. XSTEM is also evaluated for the treatment of the severe and deadly lung complication ARDS, which may affect covid-19 patients.

Xintela AB (OSTO:XINT) Headlines

No Headlines